Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Primary Graft Dysfunction 1Liver Neoplasms 1Liver Failure, Acute 1Liver Failure 1Liver Diseases 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1

Interventions

atezolizumab 2Sorafenib 2Bevacizumab 2titanium silicide 1ledipasvir, sofosbuvir drug combination 1halofantrine 1genexol-PM 1durvalumab 1avatrombopag 1aumolertinib 1Sunitinib 1Ramucirumab 1Neoadjuvant Therapy 1N-monoacetylcystine 1Leucovorin 1Injections 1Immunotherapy 1Formyltetrahydrofolates 1Everolimus 1Cisplatin 1Catheter Ablation 1Adjuvants, Pharmaceutic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Diseases × halofantrine × Clear all
NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Azienda Ospedaliera di Padova

Phase 2 Completed
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡